SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

🔥 COCK Token – The Ultimate Cross-Chain MemeFi Powerhouse 🔥  In just under 20 days, $COCK has smashed expectations, broken ATHs, and built a project that’s shaking up Cardano and the entire crypto space. 🐓 What Makes $COCK Special?      The Name: Love it or hate it, the energy and engagement it generates are undeniable. The nuance in language and wild appeal set us apart.     #MEMEFI Pioneer: We’re not just another meme coin. $COCK is leading a movement by combining DeFi mechanics, game theory, and community engagement into a groundbreaking ecosystem.     COCKARENA: At the core of our ecosystem is the COCKARENA, a PvP HODL game. Players battle it out, and early exit fees fuel redistributions, burns, and the treasury. This ensures price appreciation and long-term sustainability for loyal holders.  🎰 The COCK Casino  Our casino isn’t just fun—it’s a serious revenue stream for the FLOCK.      Games: Bonanza, Crash, Blackjack, and Roulette (coming soon!).     Impact: Over 7,834 ADA in profits generated within days, directly supporting rewards, burns, and reinvestment.  💰 COCK-ARENA Loans  Unlock liquidity without selling your tokens.      Loan Terms: Borrow up to 30% of your holdings while continuing to earn rewards in the arena.     Investor Focus: Perfect for savvy investors staying in the game while tapping into their holdings.  🤝 Our Insane Partnerships  We’re bridging gaps, building alliances, and breaking barriers across the crypto space. Key Partners:      DANZO: Powering #MEMEFI with Arena, Casino, and Loans.     KLENEK: Interactive training room.     HSKN (Charles Hoskilien): Supporting and starting COCKPIN with 115 AIR NODES for DePIN aggregation. Plans to add APEX and Earth Nodes through a crypto company incorporated in Costa Rica.     ELITE CATS / SNEKKIES / HOT / BANK: Rewarding NFT holders with COCK-LOCK tokens and vice versa.     OCKZ: COCKSOCKS, Golden Cock Ticket (1M COCK), airdrop rewards, and whitelist perks for holders of 200 ADA worth of $COCK.     OLI Partnership:         Content Creation: Lux and the team are crafting engaging educational content about memes and MemeFi for OLi's platform.         Strategic Investment: The OLi Community Trust will invest in $COCK, distributing 100% of rewards to $OLI holders.         Community Reach: Over 22,000 learners will discover $COCK through OLi's gamified ecosystem.     Hi-Rez the Rapper: Expanding reach in marketing and entertainment.     KUNO, CALEB, CADEN, FITY, ROVER, WhaleInsider: Influential collaborators driving crypto adoption and growth.     Cardano Girls: Helping us understand and communicate effectively with ADA’s female audience.     WallStreetBets: Breaking barriers and increasing engagement.     Antonio Brown: Endorsing, supporting, and even playing in the casino and arena!     Advisors:         BERIS, HECKTHESNEK, RTB, CRYPTOGENIUS: Trusted names advising and supporting the project.  Future Partnerships:  More collaborations are in the pipeline to continue expanding engagement and bring new eyes to ADA and CNTs. 🔥 Unmatched Results in Just 20 Days      Supply Burned: 1.65%, worth 148K ADA!     Arena Fees Collected: 54M COCK, worth over 500K ADA, fueling rewards, burns, and partnerships.     Staked COCK-LOCK: 11M COCK-LOCK in the liquid staking platform, with more coming.     Casino Revenue: Skyrocketing profits directly rewarding holders and growing the treasury.     Top Blast Contests: Generated over 120K ADA in volume, rewarding participants with over 50K ADA in prizes.  🌍 Our Vision  To be the most decentralized, rewarding, and innovative token on Cardano while fostering cross-chain collaboration and onboarding the masses.      Breaking Barriers: We’re bringing BTC, ETH, SOL, and other chains into the fold.     Community-Driven: Focused on building bridges and showcasing that crypto can be fun, rewarding, and sustainable.     Expansion: This is just the beginning. With more burns, rewards, and partnerships on the way, $COCK is set to redefine what’s possible in the MemeFi space.  💎 Time in the arena > Timing the market. The FLOCK is unstoppable. Let’s keep breaking walls for Cardano and onboard new users as we take $COCK to new heights.

CockCardano

CockCardano ($COCK) is trending due to its unique blend of meme culture and real-world utility through Cocky Wings, a food truck business that drives token buybacks. The community is actively discussing the passive income opportunities in the $COCK Arena and the upcoming $SNEK energy drink partnership. This project stands out with its real-world asset backing and engaging community initiatives, differentiating it from typical memecoins.

Celestica, Inc. engages in the provision of supply chain solutions globally to equipment manufacturers and service providers. It operates through the following segments: Advanced Technology Solutions (ATS), and Connectivity and Cloud Solutions (CCS). The Advanced Technology Solutions (ATS) segment includes aerospace and defense, industrial, smart energy, health tech, and capital equipment businesses. The Connectivity and Cloud Solutions (CCS) segment consists of enterprise communications, telecommunications, servers, and storage businesses. The company was founded in 1994 and is headquartered in Toronto, Canada.

Celestica, Inc. - Ordinary Shares (Subordinate Voting)

Celestica, Inc.

Celestica ($CLS) is trending due to strong performance in the AI infrastructure market, with analysts highlighting its potential for further growth and comparing it to an early-stage Nvidia. Community discussions emphasize Celestica's key role in enabling Broadcom's AI networking stack and benefiting from AMD's quantum computing advancements, leading to increased investor interest and options activity. Earnings are coming up, adding to the volatility.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is trending amid mixed sentiment, with some investors expressing concerns about the company's financial outlook and others highlighting the quality of its vehicles and potential partnerships; community discussions revolve around production targets, competition in the EV market, and the impact of a recent reverse stock split.

Clanker is an autonomous agent for deploying tokens. Currently, users may request clanker to deploy an ERC-20 token on Base by tagging it @clanker on Farcaster.

tokenbot

Clanker Crypto ($CLANKER) is trending amid discussions about its recent performance and potential Coinbase listing, with the community highlighting its limited supply of one million tokens. Some users are reporting issues with trading on Coinbase, while others speculate on possible price movements and future rallies. The token's association with AI tools and the broader Base App ecosystem are also points of interest.

Solana Street Bets is not just a memecoin; it's a symbol of creativity, humor, and the power of a united community. Inspired by the infamous /wallstreetbets subreddit. Solana Street Bets is here to put respect on the Wall St originated memes in the industry. Solana Street Bets is a decentralized Solana meme coin inspired by the infamous /wallstreetbets subreddit.

SatoshiStreetBets

SatoshiStreetBets is trending as community members discuss its potential and recent BitMart listing. The project is also generating buzz around staking opportunities and upcoming events, though some users express concern over slow growth and chart performance. Community members highlight a mix of positive sentiment and caution, with discussions focusing on future catalysts.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAIL (GRAL) is trending due to positive results from its PATHFINDER 2 study, showcasing strong performance in early cancer detection, as well as a presentation at the Jefferies Global Healthcare Conference on Wednesday. Community discussions revolve around the test's potential, upcoming milestones, and the possibility of Medicare coverage, with some comparing GRAL to other high-growth potential biotech stocks. There is also chatter around a short report and whether the company will pursue a share offering.

Picard Medical, Inc. is a medical technology company, which manufactures and sells the only U.S. FDA, and Health Canada approved implantable SynCardia TAH. It develops the first fully implantable SynCardia TAH as an alternative to heart transplantation for patients with biventricular heart failure in the U.S. and around the world. The company is headquartered in Tucson, AZ.

Picard Medical Inc.

PMI is experiencing significant volatility, prompting the company to state that they are unaware of any material change to account for the stock's movements. The community is actively debating the reasons behind the price fluctuations, including speculation about dilution and potential pump-and-dump schemes, while others point to the company's technology and market position as reasons for optimism. Recent trading patterns and after-hours activity are also being closely monitored for signals about the stock's next move.

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

AVXL is trending as investors discuss the potential EMA approval of Blarcamesine, its Alzheimer's drug candidate, with a decision expected soon, sparking retail interest and a surge in options trading. Community discussions focus on the likelihood of approval, possible partnership deals, a potential short squeeze, and the impact of analyst opinions. Some traders point to recent negative reports as FUD designed to cover shorts, while others highlight the drug's unique mechanism and potential for broad use.

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Kura Oncology Inc

Kura Oncology is trending due to mixed reactions to its recent collaboration with Kyowa Kirin, impacting its U.S. commercial rights for Ziftomenib; the community is actively discussing the deal's financial implications and Kura's future prospects, with some seeing it as a derisking event while others question the long-term benefits and potential buyout scenarios.

The ArcBlock project was created to create the first Blockchain ecosystem in the world. Develop and develop decentralized applications (DApp) according to objectives. ArcBlock, one of the ICO projects emerging in early 2018. Just launched on 3/1/2018, ArcBlock has quickly attracted the attention of technology as well as investors. ArcBlock brings great technological advancements that will open the third generation of blockchain applications.  Arcblock work by bridging the gap between different blockchains and their respective ecosystems has not been easy. There are some solutions which attempt to solve this problem, but it is evident there is plenty of room for competition in this regard. Building an open chain access layer capable of spanning multiple new and existing blockchains is a very interesting business model.  Building a new ecosystem meant to connect various chains will not be easy. As of right now, the team has completed its token sale, and the first public release candidate for the Open Chain Access Protocol will be released in Q3. Early 2019 will herald the introduction of more technical features and an Ethereum Blocklet prototype.

ABT is trending amidst community frustration with price action and disappointment in 

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here's Why Inventiva (IVA) Is a Great 'Buy the Bottom' Stock Now

Inventiva (IVA) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

How Much Upside is Left in Inventiva (IVA)? Wall Street Analysts Think 100.79%

The mean of analysts' price targets for Inventiva (IVA) points to a 100.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Inventiva (IVA) Upgraded to Buy: What Does It Mean for the Stock?

Why Is Fatty-Liver Drug Developer Inventiva Stock Trading Higher On Monday?

Inventiva secures 94.1M in financing, potentially reaching 348M, to fund the Phase 3 NATiV3 trial for lanifibranor in NASH. Leadership changes include new chairman and director appointments.
read...

Inventiva Advances Lanifibranor Trial with Promising Data

Inventiva (IVA) has released an update. Inventiva reports strong progress in its NATiV3 Phase III clinical trial for lanifibranor, with over 80% en...

FY2025 Earnings Forecast for Inventiva S.A. (NASDAQ:IVA) Issued By HC Wainwright

Inventiva S.A. (NASDAQ:IVA - Free Report) - Equities research analysts at HC Wainwright increased their FY2025 earnings per share estimates for shares of Inventiva in a report issued on Monday...

Inventiva announces filing of its 2023 Universal Registration Document and 2023 Annual Report on Form 20-F

Daix (France), Long Island City (New York, United States), April 3, 2024 Inventiva (Euronext Paris and Nasdaq: IVA) (the Company ), a clinical-stage biopharmaceutical company focused on the...

Brokerages Set Inventiva S.A. (NASDAQ:IVA) Price Target at $15.67

Inventiva S.A. (NASDAQ:IVA - Get Free Report) has been given an average recommendation of "Buy" by the eight brokerages that are covering the firm, MarketBeat.com reports. Eight investment analysts...

Buy Rating Affirmed: Inventiva's Progress and Promise in Lanifibranor's Clinical Trials

Analyst Ed Arce of H.C. Wainwright maintained a Buy rating on Inventiva (IVA Research Report), retaining the price target of $22.00. Ed Arce has...

Full Year 2023 Inventiva SA Earnings Call Transcript

Inventiva SA is a clinical-stage biopharmaceutical company, which focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis, or NASH, and other diseases with significant unmet medical need. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centered on transcription factors, epigenetics targets, and nuclear receptors. The company was founded by Pierre Broqua and Frédéric Cren on October 27, 2011 and is headquartered in Daix, France.

Inventiva - ADR

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

Current Price	$6.20
Prev Close	$5.87
Open	$5.87
Dividend Yield	0.00%
50-Day Moving Average	$5.40
Beta	0.64
Avg. Volume	65,695.10
PE Ratio	-1.52

52-Week High	$6.55
52-Week Low	$2.11
Market Capitalization	$443.69M
EPS (Annual)	-$3.33
Price to Book	-78.64
Revenue Per Employee	$83,608.34
Enterprise Value/EBITDA	N/A

IVA
Inventiva - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IVA News

IVAInventiva - ADR